The use of FDA-approved medications for preventing vaso-occlusive events in sickle cell disease

Blood Adv. 2023 Jul 11;7(13):3114-3116. doi: 10.1182/bloodadvances.2022008965.

Robert M Cronin¹, Chyongchiou J Lin², ChienWei Chiang^{3

4}, Sarah R MacEwan¹, Michael R DeBaun⁵, J Madison Hyer^{3

4

6}

¹ Department of Internal Medicine, The Ohio State University, Columbus, OH.
² College of Nursing, The Ohio State University, Columbus, OH.
³ Department of Biomedical Informatics, The Ohio State University, Columbus, OH.
⁴ Secondary Data Core, The Ohio State University, Columbus, OH.
⁵ Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.
⁶ Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, OH.

No abstract available

MeSH terms